Search by Drug Name or NDC
NDC 24075-0411-05 Conjupri 2.5 mg/2.5mg Details
Conjupri 2.5 mg/2.5mg
Conjupri is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by CSPC Ouyi Pharmaceutical Co. Ltd. The primary component is LEVAMLODIPINE MALEATE.
Product Information
| NDC | 24075-0411 |
|---|---|
| Product ID | 24075-0411_73a7640c-b052-4124-be20-04ed75c6a665 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Conjupri |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | levamlodipine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/2.5mg |
| Substance Name | LEVAMLODIPINE MALEATE |
| Labeler Name | CSPC Ouyi Pharmaceutical Co. Ltd |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA212895 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24075-0411-05 (24075041105)
| NDC Package Code | 24075-0411-5 |
|---|---|
| Billing NDC | 24075041105 |
| Package | 2.5 mg in 1 BOTTLE (24075-0411-5) |
| Marketing Start Date | 2021-10-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |